Three prerequisites must be met to encourage non pilot cities to participate in "4 + 7"
-
Last Update: 2019-03-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In recent years, with the release of landing documents in each pilot city, how will the linkage between non pilot areas be conducted after the 4 + 7 volume purchase pilot? There has been a lot of discussion in the industry Yesterday (February 28), Liaoning Province medicine and medical consumables centralized purchase network issued the notice on solidly and steadily promoting the pilot work of national organization of centralized purchase and use of drugs (hereinafter referred to as the notice), in which, there is a clause in the notice that explicitly encourages other non pilot cities to participate in the pilot work According to the notice, in addition to Shenyang and Dalian, other cities are encouraged to participate in the pilot project with the city as the unit on the premise of meeting the purchase and use volume, medical insurance payment policy and drug payment settlement Other cities that are willing to participate in the pilot project can apply for participation in the pilot project in the name of the municipal government to the leading group for centralized purchase of drugs and medical consumables of medical institutions in Liaoning Province Then, the office of the leading group for centralized procurement of drugs and medical consumables of medical institutions in Liaoning Province applied to the national pilot group for centralized procurement and use of drugs, and communicated with the relevant drug selection enterprises With the approval of the state and the approval of the relevant drug selection enterprises, the relevant preparatory work shall be started, and the implementation scheme, supporting measures and relevant working system shall be implemented after the approval of the leading group for centralized procurement of drugs and medical consumables of medical institutions in Liaoning Province Some analysts pointed out that the three conditions of "purchase usage", "medical insurance payment policy" and "drug payment settlement" were used as the pilot premise in Liaoning, which basically met the requirements of the industry reiterating that non pilot areas were not encouraged to consider "volume price linkage" In addition to encouraging the participation of non pilot cities, Liaoning has also made specific requirements for the formal launch of two pilot cities in the province According to the requirements of the notice, public health institutions in Shenyang and Dalian will implement the national centralized procurement results on March 20 As for the most concerned drug payment settlement issues of pharmaceutical enterprises, the notice reiterates that it is necessary to ensure the timely settlement of drug payment in accordance with the implementation opinions on the pilot work of centralized purchase and use of drugs organized by the state (lhdl (2019) No 2), and the settlement is completed in the next month when the drugs are put into storage, in principle, no more than 30 days Encourage the exploration of direct settlement of medical insurance funds It is pointed out that whether it is medical and health institutions or medical insurance funds that directly settle accounts (advance payments), the objects are all drug manufacturers In promoting the pilot work, all localities should grasp it correctly, and should not confuse the main responsibility due to improper grasp, which will bring adverse effects on the smooth promotion of the pilot work The notice also stressed that it is necessary to speed up the formulation of supporting measures In accordance with the requirements of the opinions on the implementation of the pilot work of centralized drug procurement and use organized by the state (No 2, 2019), in addition to improving supporting measures and relevant working systems, it is necessary to carefully sort out the risk points, develop emergency plans and risk prevention and response measures At the same time, Shenyang and Dalian should evaluate each variety and refine risk prevention measures according to the specific situation of the use of national centralized purchasing products in the two cities We should sort out the work items, improve the effectiveness of the work, speed up the work progress, and be fully prepared to ensure the smooth and orderly pilot work On the same day, Liaoning provincial centralized procurement network of drugs and medical consumables also released the notice on preparations for launching the pilot of centralized procurement and use of drugs organized by the state According to the notice, the establishment of distribution relationship of selected drugs and the opening of account of medical and health institutions should be completed in time Specifically, the selected drugs can be directly distributed by the selected drug manufacturer or distributed by a selected drug manufacturer according to the principle that each city entrusts no more than one distribution enterprise The drug manufacturer should build the centralized purchasing platform of drugs and medical consumables in Liaoning Province before 17:00 on March 5 Establish and change the distribution relationship At the same time, medical and health institutions should be organized to sign the "purchase and sale contract of pilot volume of centralized purchase and use of drugs organized by the state" with the selected drug production (distribution) enterprises Shenyang and Dalian are required to reduce the purchase volume to all medical and health institutions as soon as possible, and organize medical and health institutions to complete the production of selected drugs before 17:00 on March 15 (distribution) the enterprise shall, in accordance with the relevant provisions, sign the purchase and sale contract for centralized purchase and pilot use of drugs organized by the state The contract shall specify the purchase quantity, purchase amount, delivery place, settlement method and other relevant contents of the selected drugs In addition to Shenyang and Dalian, with the continuous promotion of 4 + 7 volume procurement, the landing work of other pilot cities is also in the process of "speeding up" On February 27, Shenzhen quanyao.com issued a notice that it will carry out the information maintenance work of 4 + 7 urban drug centralized purchase and selection On February 26, Shanghai Sunshine pharmaceutical purchase network issued the notice on the results of the successful selection of the implementation of 4 + 7 urban drug centralized purchase in this city, stating that the winning result of this round of centralized purchase will be officially implemented on March 20, and a series of supporting measures will be issued to implement the use of the centralized purchase of drugs On the same day, Beijing Pharmaceutical centralized procurement service center issued a document, which publicized the results of the pilot drug centralized procurement and use and the relevant information of the enterprises entrusted by the selected production enterprises, and informed all relevant units to prepare for the implementation in advance And almost at the same time, the further negotiation and negotiation of the unselected varieties in the 4 + 7 centralized procurement are also being carried out in different forms in Guangdong and other places With the launch of the supporting rules for the pilot drug centralized purchase and use in various regions organized by the state, it can be said that the new policy that shakes the industry will usher in the peak of implementation in this spring While the first batch of pilot projects has not yet been implemented, the news that the second batch of pilot projects will be launched in the middle of this year is spreading in the industry, and the industry will always pay attention to the progress and continuation of this new deal.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.